Expression of apoptosis-regulating miRNAs and target mRNAs in oral squamous cell carcinoma

Cancer Genetics

Volumn 208, Issue 7-8, 2015, Pages 382-389

  Coutinho Camillo, Cláudia Malheiros ^a   Lourenço, Silvia Vanessa ^b   de Araújo Lima, Leandro ^b   Kowalski, Luiz Paulo ^a   Soares, Fernando Augusto ^a,b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Gene expression; miRNA; Oral squamous cell carcinoma; Real time PCR

Indexed keywords

CASPASE 2; CASPASE 7; CASPASE 8; MESSENGER RNA; MICRORNA; MICRORNA 15A; MICRORNA 16; MICRORNA 17-5P; MICRORNA 20A; MICRORNA 21; MICRORNA 29A; MICRORNA 34A; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG; CASP2 PROTEIN, HUMAN; CASP7 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; CYSTEINE PROTEINASE; DIABLO PROTEIN, HUMAN; MIRN15 MICRORNA, HUMAN; MIRN16 MICRORNA, HUMAN; MIRN17 MICRORNA, HUMAN; MIRN20 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN29 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN; MITOCHONDRIAL PROTEIN; SIGNAL PEPTIDE;

ADULT; APOPTOSIS; ARTICLE; BCL2 GENE; CASP2 GENE; CASP7 GENE; CASP8 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABLO GENE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 2; CASPASE 7; CASPASE 8; CYSTEINE ENDOPEPTIDASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MOUTH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84939466134     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2015.04.004     Document Type: Article

References (58)

1. Wu B.H., Xiong X.P., Jia J., et al. MicroRNAs: new actors in the oral cancer scene. Oral Oncol 2011, 47:314-319.
2. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
3. Wang Y., Lee C.G. MicroRNA and cancer-focus on apoptosis. J Cell Mol Med 2009, 13:12-23.
4. Farazi T.A., Spitzer J.I., Morozov P., et al. miRNAs in human cancer. J Pathol 2011, 223:102-115.
5. Lynan-Lennon N., Maher S.G., Reynolds J.V. The roles of microRNA in cancer and apoptosis. Biol Rev 2009, 84:55-71.
6. Lima R.T., Busacca S., Almeida G.M., et al. MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 2011, 47:163-174.
7. Subramanian S., Steer C.J. MicroRNAs as gatekeepers of apoptosis. J Cell Physiol 2010, 223:289-298.
8. Wang Z. MicroRNA: a matter of life or death. World J Biol Chem 2010, 1:41-54.
9. Yang B.F., Lu Y.J., Wang Z.G. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin Exp Pharmacol Physiol 2009, 36:951-960.
10. Hayes J., Peruzzi P.P., Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 2014, 20:460-469.
11. Chen Y., Fu L.L., Wen X., et al. Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy. Apoptosis 2014, 19:1177-1189.
12. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012, 4:143-159.
13. Lajer C.B., Nielsen F.C., Friis-Hansen L., et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 2011, 104:830-840.
14. Liu X., Chen Z., Yu J., et al. MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009, 837514.
15. Gomes C.C., Gomez R.S. MicroRNA and oral cancer: future perspectives. Oral Oncol 2008, 44:910-914.
16. Avissar M., McClean M.D., Kelsey K.T., et al. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009, 30:2059-2063.
17. Reis P.P., Tomenson M., Cervigne N.K., et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 2010, 9:238.
18. Li J., Huang H., Sun L., et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009, 15:3998-4008.
19. Schoelch M.L., Le Q.T., Silverman S., et al. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999, 35:77-85.
20. Nylander K., Dabelsteen E., Hall P.A. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. JOP 2000, 29:413-425.
21. Loro L.L., Vintermyr O.K., Johannessen A.C. Cell death regulation in oral squamous cell carcinoma: methodological considerations and clinical significance. J Oral Pathol Med 2003, 32:125-138.
22. Andreassakis D., Lazaris A.C., Tsiambas E., et al. Evaluation of caspase-3 and caspase-8 deregulation in tongue squamous cell carcinoma, based on immunohistochemistry and computerised image analysis. J Laryngol Otol 2008, 122:1213-1218.
23. Singh B.B., Chandler F.W., Whitaker S.B., et al. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85:692-698.
24. Xie X., Clausen O.P., De Angelis P., et al. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in OSCC of the tongue. Cancer 1999, 86:913-920.
25. Coutinho-Camillo C.M., Lourenço S.V., Nishimoto I.N., et al. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology 2010, 57:304-316.
26. Coutinho-Camillo C.M., Lourenço S.V., Nishimoto I.N., et al. Caspase expression in oral squamous cell carcinoma. Head Neck 2011, 33:1191-1198.
27. Coutinho-Camillo C.M., Lourenço S.V., Nonogaki S., et al. Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas. Virchows Arch 2013, 463:313-319.
28. World Health Organization The World Health Organization report 2003 2003, 6-7. World Health Organization, Geneva, Switzerland.
29. da Saúde M. Instituto Nacional de Câncer. Estimativa/2014: incidência de câncer no Brasil 2013, INCA, Rio de Janeiro, Brazil.
30. R Development Core Team R: a language and environment for statistical computing 2010, R Foundation for Statistical Computing, Vienna, Austria.
31. Sales G., Coppe A., Bisognin A., et al. MAGIA, a web-based tool for miRNA and Genes Integrated Analysis. Nucleic Acids Res 2010, 38:W352-W359.
32. Cimmino A., Calin G.A., Fabbri M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102:13944-13949.
33. Khan Z., Bisen P.S. Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer. Biochim Biophys Acta 2013, 1836:123-145.
34. Camisasca D.R., Honorato J., Bernardo V., et al. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol 2009, 45:225-233.
35. Bommer G.T., Gerin I., Feng Y., et al. p53-Mediated Activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007, 17:1298-1307.
36. Chang T.C., Wentzel E.A., Kent O.A., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752.
37. He L., He X., Lim L.P., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
38. Raver-Shapira N., Marciano E., Meiri E., et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26:731-743.
39. Tarasov V., Jung P., Verdoodt B., et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6:1586-1593.
40. Tassone P., Old M., Teknos T.N., et al. p53-based therapeutics for head and neck squamous cell carcinoma. Oral Oncol 2013, 49:733-737.
41. Arora S., Aggarwal P., Pathak A., et al. Molecular genetics of head and neck cancer (Review). Mol Med Rep 2012, 6:19-22.
42. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
43. Jones M., Lal A. MicroRNAs, wild-type and mutant p53: more questions than answers. RNA Biol 2012, 9:781-791.
44. Park S., Lee J.H., Ha M., et al. miR-29 miRNAs activate p53 by targeting p85a and CDC42. Nat Struct Mol Biol 2009, 16:23-29.
45. Mott J.L., Kobayashi S., Bronk S.F., et al. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
46. Chen L., Willis S.N., Wei A., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005, 7:393-403.
47. Yan H.L., Xue G., Mei Q., et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 2009, 28:2719-2732.
48. O'Donnell K.A., Wentzel E.A., Zeller K.I., et al. cMyc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
49. He L., Thomson J.M., Hemann M.T., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
50. Matsubara H., Takeuchi T., Nishikawa E., et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 2007, 26:6099-6105.
51. Xiao C., Srinivasan L., Calado D.P., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008, 9:405-414.
52. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65:6029-6033.
53. Meng F., Henson R., Wehbe-Janek H., et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
54. Si M.L., Zhu S., Wu H., et al. miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
55. Severino P., Oliveira L.S., Torres N., et al. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research. BMC Genomics 2013, 14:735.
56. Zhu S., Si M.L., Wu H., et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282:14328-14336.
57. Yan L.X., Huang Y.F., Shao Q. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14:1-13.
58. Schetter A.J., Leung S.Y., Sohn J.J., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.